Sung Ho Park, MD, Seong-il Oh, MD, PhDa , Jun Ho Lee, MD, Kyong Jin Shin, MD, PhD
Department of Neurology, Haeundae-Paik Hospital, Inje University College of Medicine, Busan, Korea Department of Neurology, Busan Paik Hospital, Inje University College of Medicine, Busan, Koreaa
Myelin oligodendrocyte glycoprotein antibody disease (MOGAD) has recently been considered
as a new neurological disease with distinct clinical and radiological characteristics different from
multiple sclerosis (MS) and aquaporin-4 (AQP4) antibody-positive neuromyelitis optica spectrum
disorder (NMOSD). Recently, we experienced a case of MOGAD in a patient who showed
overlapping clinical and radiological features of MS and AQP4-positive NMOSD.
Journal of Multiple Sclerosis and Neuroimmunology 11(2):68-71, 2020
